Abaxis, Inc. to Present at Needham & Company's Twelfth Annual Growth Stock Conference
05 1월 2010 - 9:00PM
PR Newswire (US)
UNION CITY, Calif., Jan. 5 /PRNewswire-FirstCall/ -- Abaxis, Inc.
(NASDAQ: ABAX), a medical products company manufacturing
point-of-care blood analysis systems, announced today that Clint
Severson, chairman and chief executive officer will present at
Needham & Company's Twelfth Annual Growth Stock Conference on
Thursday, January 14, 2010 at 10:00 a.m. ET. The conference will be
held at The New York Palace Hotel in New York City. About Abaxis
Abaxis develops, manufactures and markets portable blood analysis
systems for use in any veterinary or human patient-care setting to
provide clinicians with rapid blood constituent measurements. The
system consists of a compact, 5.1 kilogram (11.2 pounds), portable
analyzer and a series of single-use plastic discs, called reagent
discs that contain all the chemicals required to perform a panel of
up to 13 tests on veterinary patients and 14 tests on human
patients. The system can be operated with minimal training and
performs multiple routine tests on whole blood, serum or plasma
samples. The system provides test results in less than 12 minutes
with the precision and accuracy equivalent to a clinical laboratory
analyzer. Contact: Clint Severson Lytham Partners, LLC Chief
Executive Officer Joe Dorame, Joe Diaz & Robert Blum ABAXIS,
Inc. 602-889-9700 510-675-6500 DATASOURCE: Abaxis, Inc. CONTACT:
Clint Severson, Chief Executive Officer of ABAXIS, Inc.,
+1-510-675-6500; or Joe Dorame, Joe Diaz & Robert Blum, all of
Lytham Partners, LLC, +1-602-889-9700, for ABAXIS, Inc.
Copyright